带有呼吸衰竭和dysautonomia的肌缩侧硬化症:一个病例报告
Subodh Chapagain1, Nirajan Khati1, Roshani Lama2
1Kathmandu Medical College and Teaching Hospital, Sinamangal.
Annals of medicine and surgery (2012)
|July 10, 2023
概括
肌缩侧面硬化症 (ALS) 可以影响自主神经系统,导致血压问题. 早期诊断和管理,包括通风和药物治疗,对于患有ALS和dysautonomia的患者来说至关重要.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
- 自主神经系统的自主神经系统
背景情况:
- 肌缩侧面硬化症 (ALS) 主要影响运动神经元,但可以表现出非运动症状.
- 最近的发现表明,在ALS中自主神经系统参与,导致像正静性低血压和血压变化等症状.
研究的目的:
- 突出ALS中dysautonomia的发生和影响.
- 强调早期诊断和ALS患者自主功能障碍综合管理策略的重要性.
主要方法:
- 一个58岁的男性被诊断出患有ALS和呼吸衰竭的dysautonomia的案例介绍.
- 审查导致ALS中dysautonomia的机制,包括运动神经元病变和肌肉缩.
- 讨论目前对ALS的管理方法.
主要成果:
- 患者经历了渐进的运动软弱和显著的血压波动,需要密集护理和非侵入性通风.
- 在ALS中,失自性可能源于运动神经元损伤,肌肉缩和呼吸支持.
结论:
- 有效的ALS治疗需要早期诊断,疾病修饰药物 (例如,riluzole),营养支持和非侵入性通风.
- 解决非运动性症状,特别是dysautonomia,对于改善ALS患者的生存率和生活质量至关重要.
相关概念视频
Acute Respiratory Failure-III
227
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
227
Acute Respiratory Failure-IV
177
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
177
Acute Respiratory Failure-V
166
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Acute Respiratory Failure-I
251
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
251
Acute Respiratory Failure-II
278
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278


